Company Filing History:
Years Active: 2023
Title: Gabriella Ferrara: Innovator in Haemostatic Composition
Introduction
Gabriella Ferrara, an accomplished inventor based in Old Tappan, NJ, has made significant contributions to the medical field through her innovative ideas and inventions. With a focus on developing advanced solutions for wound treatment, she holds one patent which showcases her dedication to improving patient care.
Latest Patents
Ferrara's notable patent is titled "Method for preparing a haemostatic composition." This invention relates to a unique method of preparing a haemostatic composition that comprises thrombin. The innovative process involves reconstituting dry thrombin directly into a biocompatible polymer paste. This technique allows for the rapid production of a haemostatic agent in a single step, which can be used effectively for treating wounds, thereby enhancing medical procedures.
Career Highlights
Throughout her career, Gabriella Ferrara has worked with prominent companies in the medical device industry, including Ferrosan Medical Devices A/S and Ethicon GmbH. Her experience in these organizations has facilitated her growth as an inventor and has allowed her to contribute to the development of life-saving medical technologies.
Collaborations
Collaboration has been a key aspect of Ferrara’s innovative journey. She has worked alongside talented professionals such as Peter Lund Hammershøj and Kristian Larsen. These collaborations have enriched her research and development process, ultimately leading to the successful realization of her inventive ideas.
Conclusion
Gabriella Ferrara's inventive spirit and dedicated approach to the medical field have led to significant advancements in wound treatment technologies. Her patent for a haemostatic composition not only showcases her innovative skills but also reflects her commitment to enhancing patient care. As she continues her work, the impact of her inventions will likely resonate within the medical community and improve outcomes for patients worldwide.